X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (50453) 50453
Newsletter (13479) 13479
Book Review (5348) 5348
Publication (4887) 4887
Newspaper Article (732) 732
Book Chapter (445) 445
Conference Proceeding (417) 417
Dissertation (179) 179
Magazine Article (108) 108
Book / eBook (35) 35
Web Resource (25) 25
Trade Publication Article (12) 12
Reference (7) 7
Data Set (4) 4
Journal / eJournal (4) 4
Paper (4) 4
Streaming Video (3) 3
Government Document (2) 2
Presentation (2) 2
Transcript (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (35316) 35316
humans (33058) 33058
glioblastoma multiforme (26156) 26156
glioblastoma (22718) 22718
oncology (16428) 16428
cancer (15335) 15335
male (12775) 12775
female (12567) 12567
research (12021) 12021
brain neoplasms - pathology (10140) 10140
glioblastoma - pathology (9930) 9930
animals (9917) 9917
middle aged (9705) 9705
adult (8979) 8979
gliomas (8729) 8729
brain tumors (8701) 8701
clinical neurology (8645) 8645
glioma (8631) 8631
cell line, tumor (7907) 7907
tumors (7880) 7880
aged (7362) 7362
care and treatment (6581) 6581
expression (5865) 5865
reports (5852) 5852
prognosis (5807) 5807
mice (5800) 5800
apoptosis (5799) 5799
glioblastoma - metabolism (5689) 5689
chemotherapy (5462) 5462
radiotherapy (5434) 5434
surgery (5352) 5352
glioblastoma - genetics (5260) 5260
analysis (5206) 5206
temozolomide (5031) 5031
brain neoplasms - metabolism (5025) 5025
glioblastoma - drug therapy (5021) 5021
brain neoplasms - genetics (5008) 5008
survival (4986) 4986
glioblastoma-multiforme (4854) 4854
brain neoplasms - drug therapy (4802) 4802
brain (4494) 4494
cell biology (4288) 4288
glioma - pathology (4268) 4268
brain cancer (4231) 4231
genetic aspects (4206) 4206
neurosciences (4075) 4075
brain-tumors (3701) 3701
magnetic resonance imaging (3637) 3637
gene expression (3636) 3636
malignant glioma (3632) 3632
medicine & public health (3392) 3392
universities and colleges (3325) 3325
brain neoplasms - therapy (3323) 3323
health aspects (3257) 3257
biochemistry & molecular biology (3218) 3218
stem cells (3158) 3158
medical research (2980) 2980
proteins (2961) 2961
article (2946) 2946
development and progression (2897) 2897
glioblastoma - therapy (2895) 2895
growth (2858) 2858
tumor cells, cultured (2856) 2856
adolescent (2846) 2846
neurology (2790) 2790
radiology, nuclear medicine & medical imaging (2736) 2736
immunohistochemistry (2729) 2729
brain neoplasms - mortality (2647) 2647
cells (2639) 2639
cell proliferation (2626) 2626
angiogenesis (2588) 2588
pathology (2580) 2580
brain neoplasms - surgery (2567) 2567
treatment outcome (2513) 2513
gene expression regulation, neoplastic (2489) 2489
therapy (2489) 2489
malignant gliomas (2451) 2451
brain neoplasms - diagnosis (2443) 2443
brain neoplasms - radiotherapy (2410) 2410
glioblastoma - radiotherapy (2359) 2359
dacarbazine - analogs & derivatives (2346) 2346
signal transduction (2333) 2333
in-vivo (2325) 2325
drugs (2297) 2297
mice, nude (2290) 2290
medicine, experimental (2279) 2279
mutation (2277) 2277
glioma - genetics (2269) 2269
glioblastoma - mortality (2263) 2263
child (2252) 2252
glioma - metabolism (2216) 2216
radiation (2179) 2179
astrocytoma (2178) 2178
proliferation (2167) 2167
in-vitro (2159) 2159
invasion (2113) 2113
glioblastoma - diagnosis (2103) 2103
immunotherapy (2093) 2093
glioblastoma - surgery (2092) 2092
medicine, research & experimental (2091) 2091
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (62674) 62674
French (648) 648
German (614) 614
Japanese (439) 439
Spanish (236) 236
Russian (233) 233
Chinese (209) 209
Italian (100) 100
Polish (82) 82
Portuguese (73) 73
Korean (54) 54
Czech (53) 53
Turkish (38) 38
Hungarian (32) 32
Danish (15) 15
Slovak (9) 9
Croatian (8) 8
Romanian (8) 8
Serbian (8) 8
Dutch (7) 7
Swedish (7) 7
Persian (6) 6
Bulgarian (5) 5
Ukrainian (5) 5
Finnish (4) 4
Hebrew (4) 4
Norwegian (4) 4
Lithuanian (3) 3
Slovenian (3) 3
Icelandic (1) 1
Latvian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2017, ISBN 9780323476607
Web Resource
2017, ISBN 9780994438126
Glioblastoma is the commonest and the most lethal brain tumor. In this book 71 experts from around the globe come together to give a timely, unique and... 
Glioblastoma
Web Resource
2017, ISBN 9780323476607
Web Resource
JAMA, ISSN 0098-7484, 12/2017, Volume 318, Issue 23, pp. 2306 - 2316
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2010, Volume 28, Issue 31, pp. 4722 - 4729
Purpose Immunologic targeting of tumor-specific gene mutations may allow precise eradication of neoplastic cells without toxicity. Epidermal growth factor... 
MALIGNANT GLIOMA | BREAST-CANCER | CELLS | RESPONSES | GENE | ONCOLOGY | RESISTANCE | EGFRVIII | EXPRESSION | CONFERS | MULTIFORME PATIENTS | Immunohistochemistry | Predictive Value of Tests | Prognosis | Prospective Studies | Dacarbazine - therapeutic use | United States | Humans | Middle Aged | DNA Repair Enzymes - genetics | Gene Expression Regulation, Neoplastic | Male | Glioblastoma - radiotherapy | Brain Neoplasms - surgery | Cancer Vaccines - therapeutic use | DNA Methylation | Brain Neoplasms - immunology | Time Factors | Tumor Suppressor Proteins - genetics | Dacarbazine - analogs & derivatives | Adult | Female | Brain Neoplasms - mortality | Chemotherapy, Adjuvant | Brain Neoplasms - radiotherapy | Radiotherapy, Adjuvant | Injections, Intradermal | Receptor, Epidermal Growth Factor - immunology | Drug Administration Schedule | Enzyme-Linked Immunosorbent Assay | Glioblastoma - diagnosis | Brain Neoplasms - diagnosis | Brain Neoplasms - drug therapy | Glioblastoma - surgery | Antineoplastic Agents, Alkylating - therapeutic use | Cancer Vaccines - immunology | Disease-Free Survival | Magnetic Resonance Imaging | DNA Modification Methylases - genetics | Sample Size | Glioblastoma - immunology | Aged | Mutation | Glioblastoma - drug therapy | Glioblastoma - mortality | Index Medicus | temozolomide | glioblastoma multiforme | Epidermal growth factor receptors | Hypersensitivity (delayed) | Toxicity | Vaccination | Glioblastoma | Antibodies | Clinical trials | Vaccines | Survival | Immunogenicity | Point mutation | minimal residual disease | Tumors | Original Reports | Neur7 | Neur8 | Neur1
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 9, pp. 916 - 926
Journal Article
Oncogene, ISSN 0950-9232, 01/2016, Volume 35, Issue 1, pp. 12 - 21
Journal Article
Molecular Imaging and Biology, ISSN 1536-1632, 02/2014, Volume 16, Issue 1, pp. 127 - 135
Purpose: The aim of this study was to clarify the reliability of positron emission tomography (PET) using a new hypoxic cell tracer, 1-(2-[... 
Glioblastoma
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2014, Volume 370, Issue 8, pp. 699 - 708
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2014, Volume 370, Issue 8, pp. 709 - 722
In patients with glioblastoma, the addition of bevacizumab to radiotherapy and temozolomide induction therapy and the use of bevacizumab maintenance therapy... 
CONCOMITANT RADIOCHEMOTHERAPY | MEDICINE, GENERAL & INTERNAL | PHASE-II TRIAL | RECURRENT GLIOBLASTOMA | CLINICAL-TRIALS | MALIGNANT GLIOMAS | QUALITY-OF-LIFE | RESPONSE ASSESSMENT CRITERIA | MULTIFORME | HIGH-GRADE GLIOMA | ENDOTHELIAL GROWTH-FACTOR | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Induction Chemotherapy | Male | Glioblastoma - radiotherapy | Bevacizumab | Young Adult | Dacarbazine - analogs & derivatives | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Brain Neoplasms - mortality | Brain Neoplasms - radiotherapy | Angiogenesis Inhibitors - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Kaplan-Meier Estimate | Combined Modality Therapy | Brain Neoplasms - drug therapy | Disease-Free Survival | Quality of Life | Aged | Glioblastoma - drug therapy | Glioblastoma - mortality | Dosage and administration | Research | Temozolomide | Drug therapy, Combination | Drug therapy | Glioblastoma multiforme | Nuclear magnetic resonance--NMR | Intravenous administration | Glucocorticoids | Brain cancer | Body weight | Glioblastoma | Radiation therapy | Survival | Patients | Quality of life | Vascular endothelial growth factor | Index Medicus | Abridged Index Medicus | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2/2012, Volume 109, Issue 8, pp. 3041 - 3046
Glioblastoma (GBM) is distinguished by a high degree of intratumoral heterogeneity, which extends to the pattern of expression and amplification of receptor... 
Tumor cell line | Glioma | Glioblastoma | Cell lines | Cell separation | Genetic mutation | Genotypes | Tumors | Cancer | Daughter cells | Mosaicism | Amplicon | Glioblastoma genetics | MULTIDISCIPLINARY SCIENCES | RECURRENT GLIOBLASTOMA | TUMORIGENICITY | CANCER | MULTIFORME | PHASE-II TRIAL | THERAPY | mosaicism | COPY NUMBER | glioma | GENE AMPLIFICATION | MALIGNANT GLIOMAS | amplicon | MEDULLOBLASTOMA | glioblastoma genetics | Receptor, Epidermal Growth Factor - genetics | Glioblastoma - enzymology | Cell Proliferation | Humans | In Situ Hybridization, Fluorescence | Genetic Heterogeneity | Genome, Human - genetics | Intercellular Signaling Peptides and Proteins - metabolism | Gene Amplification | Glioblastoma - genetics | Receptor, Platelet-Derived Growth Factor alpha - genetics | Computer Simulation | Glioblastoma - pathology | Chromosome Segregation - genetics | Tyrosine | Receptors | Blood platelets | Physiological aspects | Development and progression | Genetic aspects | Health aspects | Phosphotransferases | Glioblastoma multiforme | Molecules | Kinases | Cells | Deoxyribonucleic acid--DNA | Fluorescence in situ hybridization | Platelet-derived growth factor receptors | Epidermal growth factor receptors | Hepatocyte growth factor | Tumor cells | Clinical trials | Genomes | 1-Phosphatidylinositol 3-kinase | c-Met protein | Protein-tyrosine kinase receptors | Atlases | DNA sequencing | Index Medicus | Biological Sciences
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 10, pp. 1100 - 1108
Journal Article